Curium Announces First Patients in Europe Injected With PYLCLARI® – an Innovative 18F-PSMA Pet Tracer Indicated in Patients With Prostate Cancer
PARIS, Nov. 16, 2023 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that in partnership with